Stefano Carlo P.
- Country
- Italy
- Department
- UO Neurologia
Research Overview
- Phase 1b/2 Study of IM-101 in Adult Participants with Generalized and Ocular Myasthenia Gravis
- Phase 3 Study of Delpacibart Zotadirsen in Duchenne Muscular Dystrophy with Mutations Amenable to Exon 44 Skipping
- A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
Data & Insights
Has run more than one trial at 61 of 202 partner sites.
Specializations
Neuromuscular Disorders
This investigator specializes in treating Duchenne Muscular Dystrophy (DMD), conducting research on innovative genetic therapies and muscle restoration approaches. Their work includes evaluation of exon skipping treatments and cell-mediated therapeutic strategies.
- Dystrophin protein restoration
- Genetic correction techniques
- Mesoangioblast cell therapy
Inflammatory Conditions
The investigator focuses on Idiopathic Inflammatory Myopathies (IIM) and Polymyositis/Dermatomyositis, studying novel therapeutic approaches including immunomodulatory treatments and targeted biological therapies.
- Inflammatory muscle disorders
- Immunological interventions
- Disease activity assessment
Neurological Disorders
Research expertise extends to various neurological conditions including Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy, and Diabetic Peripheral Neuropathy.
- Neuropathy treatment approaches
- Pain management strategies
- Neuromuscular junction disorders
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.